Literature DB >> 7897366

Complete nucleotide sequence of a strain of coxsackie B4 virus of human origin that induces diabetes in mice and its comparison with nondiabetogenic coxsackie B4 JBV strain.

Y Kang1, N K Chatterjee, M J Nodwell, J W Yoon.   

Abstract

The E2 strain of coxsackie B4 virus (CB4), which is of human origin, can induce a diabetes-like syndrome in mice. The cDNA of the genome of the E2 strain was cloned and sequenced. The E2 viral genome was found to comprise 7,396 bases, which appear to encode a polyprotein of 2,183 amino acids with an overall similarity of 94.91% to nondiabetogenic CB4 prototype JBV strain. The E2 genome is organized like other enteroviruses. It has a 5' noncoding region of 744 nucleotides, a single long open translational reading frame starting at nucleotide 745 and extending to nucleotide 7293, a 3' noncoding region of 100 nucleotides, and a poly (A) tract. Genomic sequence comparison of the E2 and JBV strains showed 1,369 nucleotide substitutions in the genome of the E2 strain, most of which are single and silent. There were 111 resultant amino acid changes arising from some of these substitutions, including 82 amino acid changes in the noncapsid proteins, and 29 amino acid changes in the capsid proteins VP1, VP2, VP3, and VP4, which showed 11, 13, 4, and 1 substitution(s), respectively. Noncapsid protein P2-C showed eight amino acid substitutions. On the basis of the sequence comparison of E2 and JBV strains of CB4, we suggest that some of the amino acid changes in the capsid and noncapsid proteins of the E2 strain may be involved in the determination of its diabetogenicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7897366     DOI: 10.1002/jmv.1890440408

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  16 in total

1.  Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.

Authors:  M K Slifka; R Pagarigan; I Mena; R Feuer; J L Whitton
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 2.  Virus infections and type 1 diabetes risk.

Authors:  Merja Roivainen; Karin Klingel
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

Review 3.  Diabetic aggravation of stroke and animal models.

Authors:  Ashish K Rehni; Allen Liu; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Exp Neurol       Date:  2017-03-06       Impact factor: 5.330

Review 4.  MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections.

Authors:  Sonia R Isaacs; Jie Wang; Ki Wook Kim; Congcong Yin; Li Zhou; Qing Sheng Mi; Maria E Craig
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

5.  Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.

Authors:  Toru Kanno; Kisoon Kim; Ken Kono; Kristen M Drescher; Nora M Chapman; Steven Tracy
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Molecular analysis of an echovirus 3 strain isolated from an individual concurrently with appearance of islet cell and IA-2 autoantibodies.

Authors:  Ciğdem H Williams; Sami Oikarinen; Sisko Tauriainen; Kimmo Salminen; Heikki Hyöty; Glyn Stanway
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

7.  Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein.

Authors:  Ruben Varela-Calvino; Ania Skowera; Sefina Arif; Mark Peakman
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  Effect of p38 mitogen-activated protein kinase on the replication of encephalomyocarditis virus.

Authors:  Kensuke Hirasawa; Angus Kim; Hye-Seung Han; Jaeseok Han; Hee-Sook Jun; Ji-Won Yoon
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

9.  HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides.

Authors:  Richard J Ellis; Ruben Varela-Calvino; Timothy I M Tree; Mark Peakman
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

10.  The use of animal models in diabetes research.

Authors:  Aileen J F King
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.